Next Article in Journal
The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
Previous Article in Journal
How do Midwives and Physicians Discuss Childhood Vaccination with Parents?
Open AccessCommunication

Cutaneous Cryptococcoma in a Patient on TNF-α Inhibition

1
PASE Healthcare, PC, 225 Millburn Avenue, Suite 303, The Common, Millburn, NJ 07041, USA
2
East Coast Advanced Plastic Surgery, 79 Hudson Street, Suite 700, Hoboken, NJ 07030, USA
3
Saint Joseph's Regional Medical Center, 703 Main Street, Paterson, NJ 07503, USA
4
Infectious Disease Center of New Jersey, 22 Old Short Hills Road, Suite 106, Livingston, NJ 07039, USA
5
Weill Cornell Medical Center, New York Presbyterian Hospital, 525 East 68th Street, New York, NY 10021, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2013, 2(4), 260-263; https://doi.org/10.3390/jcm2040260
Received: 8 October 2013 / Revised: 1 November 2013 / Accepted: 15 November 2013 / Published: 22 November 2013
An 87-year old Caucasian male with past medical history of rheumatoid arthritis (RA) and chronic kidney disease presents with left hand erythema, pain, tenderness, induration and edema. Clinically, these hand findings began proximal to the metacarpo-phalangeal joints and extended to the distal wrist. He was noted to have ipsilateral axillary lymph node enlargement but denied any constitutional signs or symptoms. Laboratory markers of inflammation were poor prognostic indicators due to relatively active RA, the use of chronic daily glucocorticoids and weekly adalimumab use. Oral antibiotics were administered with limited success leading to a skin biopsy which reported a hematogenously disseminated fungal panniculitis; cultures grew Cryptococcus neoformans, however, serum cryptococcal antigen was negative. With initial fluconazole treatment, skin findings and lymphadenopathy improved gradually over the next six months. However, the patient’s improvement stagnated and his condition reverted back to the state of initial presentation. View Full-Text
Keywords: panniculitis; Cryptococcus neoformans; adalimumab; TNF-α inhibitor; fluconazole panniculitis; Cryptococcus neoformans; adalimumab; TNF-α inhibitor; fluconazole
Show Figures

Graphical abstract

MDPI and ACS Style

Gomes, R.M.; Cerio, D.R.; Loghmanee, C.; McKinney, J.; Patel, M.; Miraglia, J.; Yousef-Bessler, M.; Zippin, J.H.; Schuetz, A.N.; Pinho, P.B. Cutaneous Cryptococcoma in a Patient on TNF-α Inhibition. J. Clin. Med. 2013, 2, 260-263.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop